Tubal cancer
Showing 1 - 25 of >10,000
Chemo-induced Peripheral Neuropathy Trial (N Acetylcysteine A, N Acetylcysteine B)
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy
- N Acetylcysteine A
- N Acetylcysteine B
- (no location specified)
Sep 12, 2022
Salpingectomy, Tubal Ligation, Menopause Trial in Eindhoven (Opportunistic salpingectomy / bilateral salpingectomy)
Enrolling by invitation
- Salpingectomy
- +2 more
- Opportunistic salpingectomy / bilateral salpingectomy
-
Eindhoven, NetherlandsCatharina Ziekenhuis
Nov 8, 2022
Epithelial Ovarian Cancer Trial in Singapore (Oregovomab, Nivolumab, Chemotherapy)
Unknown status
- Epithelial Ovarian Cancer
- Oregovomab
- +2 more
-
Singapore, Singapore
- +1 more
Nov 30, 2021
Ovarian Epithelial Cancer, Carcinoma in Situ, Ovarian Cancer Trial in Worldwide (Lavage of the Cavum uteri and proximal
Completed
- Ovarian Epithelial Cancer
- +2 more
- Lavage of the Cavum uteri and proximal Fallopian tubes, performed in the luteal phase of the female cycle
-
Graz, Austria
- +13 more
Sep 1, 2022
Ovarian Epithelial Cancer, Carcinoma in Situ, Ovarian Cancer Trial in Worldwide (Speiser-catheter for uterine and tubal lavage)
Completed
- Ovarian Epithelial Cancer
- +2 more
- Speiser-catheter for uterine and tubal lavage
-
Graz, Austria
- +8 more
Sep 1, 2022
Cancer Risk, Cancer Predisposition Syndrome, Hereditary Cancer Prediction Trial in Boston (Samples)
Not yet recruiting
- Cancer Risk
- +30 more
- Samples
-
Boston, MassachusettsDana Farber Cancer Institute
Jul 14, 2022
Ovarian Tumors Malignant (Excl Germ Cell), Peritoneal Carcinoma, Fallopian Tube Cancer Trial (trientine diHCl, pegylated
Completed
- Ovarian Neoplasms Malignant (Excl Germ Cell)
- +2 more
- trientine dihydrochloride
- +2 more
- (no location specified)
Oct 18, 2020
Contraception Trial in United States (Blood draw, ESSURE (BAY1454032), Laparoscopic tubal sterilization)
Active, not recruiting
- Contraception
- Blood draw
- +2 more
-
Chandler, Arizona
- +56 more
Jan 13, 2023
Deleterious BARD1 Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial in United States
Active, not recruiting
- Deleterious BARD1 Gene Mutation
- +13 more
- Laboratory Biomarker Analysis
- +4 more
-
Chicago, Illinois
- +8 more
Feb 25, 2022
Compare Fallopian Tube Cells Collected by Cytuity With Removed
Completed
- Fallopian Tube Cancer
- +10 more
- Hysteroscopic cell sampling of the fallopian tube
-
San Diego, California
- +9 more
Dec 30, 2020
Sterilization Tubal, Salpingectomy, Laparoscopy Trial in Göteborg (Laparoscopic tubal ligation, Laparoscopic bilateral
Recruiting
- Sterilization Tubal
- +3 more
- Laparoscopic tubal ligation
- Laparoscopic bilateral salpingectomy
-
Göteborg, SwedenSahlgrenska University Hospital
Mar 15, 2022
Ovarian Epithelial Cancer Trial in Worldwide (Lavage of the Cavum uteri and proximal fallopian tubes)
Unknown status
- Ovarian Epithelial Cancer
- Lavage of the Cavum uteri and proximal fallopian tubes
-
Vienna, Austria
- +3 more
Feb 4, 2020
Ovarian Epithelial Cancer Trial in Worldwide (Lavage of the Cavum uteri and proximal fallopian tubes, Liquid-PAP smear)
Completed
- Ovarian Epithelial Cancer
- Lavage of the Cavum uteri and proximal fallopian tubes
- Liquid-PAP smear
-
Vienna, Austria
- +5 more
Feb 21, 2020
Recurrent Ovarian Carcinoma Trial in Worldwide (Placebo, Carboplatin, Paclitaxel)
Active, not recruiting
- Recurrent Ovarian Carcinoma
- Placebo
- +6 more
-
Charleroi, Belgium
- +70 more
Feb 7, 2022
Salpingectomy, Colorectal Surgery Trial in Vancouver (Bilateral salpingectomy, Colorectal surgery)
Recruiting
- Salpingectomy
- Colorectal Surgery
- Bilateral salpingectomy
- Colorectal surgery
-
Vancouver, British Columbia, CanadaSt. Paul's Hospital
Jun 28, 2022
Prognostic Factors for Tubo-ovarian Cancer in France
Completed
- Ovarian Cancer
-
Montpellier, FranceUhmontpellier
Jan 21, 2022
Germline Variant Carriers With BRCA1 or BRCA2
Recruiting
- BRCA1 and/or BRCA2 Variant Carriers
- +3 more
-
Okayama, JapanOkayama University
Dec 25, 2022
Ovarian Cancer Stage IIIC, Fallopian Tube Cancer Stage IIIC, Fallopian Tube Cancer Stage IV Trial in Lille (Blood sample
Recruiting
- Ovarian Cancer Stage IIIC
- +3 more
- Blood sample collection
-
Lille, FranceCentre Oscar Lambret
Oct 5, 2021
Ovarian Cancer Trial in France (Collection of additional data with questionnaires)
Active, not recruiting
- Ovarian Cancer
- Collection of additional data with questionnaires
-
Bordeaux, France
- +9 more
Aug 2, 2022
Infertility Trial (Oil-based contrast, ExEm Foam)
Not yet recruiting
- Infertility
- Oil-based contrast
- ExEm Foam
- (no location specified)
Jun 1, 2023
Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer
Recruiting
- Ovarian Cancer
-
Albuquerque, New MexicoUniversity of New Mexico Cancer Center
Oct 4, 2022
Primary Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial (Huaier granule)
Not yet recruiting
- Primary Ovarian Cancer
- +2 more
- Huaier granule
- (no location specified)
Mar 29, 2023
DOvEEgene Fleur: New Uterine Sampling Tool
Recruiting
- Women With Suspected or Confirmed Gynecological Disease
- DOvEEgene Fleur Sampling
-
Montreal, Quebec, CanadaRoyal Victoria Hospital (Glen Site)
Oct 14, 2021